Arcturus Therapeutics Holdings (ARCT) Change in Cash (2018 - 2025)
Historic Change in Cash for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$16.1 million.
- Arcturus Therapeutics Holdings' Change in Cash rose 3042.63% to -$16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.8 million, marking a year-over-year increase of 2423.05%. This contributed to the annual value of -$55.0 million for FY2024, which is 2193.54% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Change in Cash is -$16.1 million, which was up 3042.63% from -$20.5 million recorded in Q2 2025.
- Over the past 5 years, Arcturus Therapeutics Holdings' Change in Cash peaked at $154.2 million during Q4 2022, and registered a low of -$63.9 million during Q1 2023.
- Over the past 5 years, Arcturus Therapeutics Holdings' median Change in Cash value was -$20.2 million (recorded in 2023), while the average stood at -$11.9 million.
- Over the last 5 years, Arcturus Therapeutics Holdings' Change in Cash had its largest YoY gain of 45546.85% in 2022, and its largest YoY loss of 138838.74% in 2022.
- Over the past 5 years, Arcturus Therapeutics Holdings' Change in Cash (Quarter) stood at -$43.4 million in 2021, then surged by 455.47% to $154.2 million in 2022, then tumbled by 113.07% to -$20.2 million in 2023, then skyrocketed by 99.26% to -$150000.0 in 2024, then tumbled by 10638.0% to -$16.1 million in 2025.
- Its Change in Cash stands at -$16.1 million for Q3 2025, versus -$20.5 million for Q2 2025 and -$20.1 million for Q1 2025.